{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:09:51Z","timestamp":1776168591722,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jcin.2025.01.424","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:31:03Z","timestamp":1739979063000},"page":"866-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["1-Month or 3-Month DAPT in Women and\u00a0Men at High Bleeding Risk Undergoing PCI"],"prefix":"10.1016","volume":"18","author":[{"given":"Vijay","family":"Kunadian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4936-3860","authenticated-orcid":false,"given":"Mauro","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-9409","authenticated-orcid":false,"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem M.","family":"Chehab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-8902","authenticated-orcid":false,"given":"Jose M.","family":"de la Torre Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell W.","family":"Krucoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Maksoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Mankerious","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Picon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-998X","authenticated-orcid":false,"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Toelg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Varenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Vranckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2025.01.424_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41569-022-00725-6","article-title":"P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention","volume":"19","author":"Capodanno","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib2","article-title":"Antiplatelet strategies following PCI: a review of trials informing current and future therapies","volume":"2","author":"Thomas","year":"2023","journal-title":"J\u00a0Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jcin.2025.01.424_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehp110","article-title":"Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial","volume":"30","author":"Mehran","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.01.424_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.424_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the Academic Research Consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.424_bib6","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2020.06.085","article-title":"Trial design principles for patients at high bleeding risk undergoing PCI: JACC scientific expert panel","volume":"76","author":"Capodanno","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4244\/EIJ-E-24-00020","article-title":"Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated","volume":"20","author":"Mehran","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.01.424_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jamacardio.2019.4296","article-title":"Association of sex with outcomes in patients undergoing percutaneous coronary intervention: a subgroup analysis of the GLOBAL LEADERS randomized clinical trial","volume":"5","author":"Chichareon","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamacardio.2021.1720","article-title":"Sex differences among patients with high risk receiving ticagrelor with or without aspirin after percutaneous coronary intervention: a subgroup analysis of the TWILIGHT randomized clinical trial","volume":"6","author":"Vogel","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib10","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.jcin.2023.08.014","article-title":"1- or 3-month DAPT in patients with HBR with or without oral anticoagulant therapy after PCI","volume":"16","author":"Valgimigli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.01.424_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ahj.2020.09.019","article-title":"Design and rationale of the XIENCE Short DAPT Clinical Program: an assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent","volume":"231","author":"Valgimigli","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2025.01.424_bib12","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.jcin.2021.07.016","article-title":"3- or 1-month DAPT in patients at high bleeding risk undergoing everolimus-eluting stent implantation","volume":"14","author":"Mehran","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.01.424_bib13","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2021.08.074","article-title":"Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI","volume":"78","author":"Valgimigli","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib14","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.424_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.112.108290","article-title":"Women, bleeding, and coronary intervention","volume":"127","author":"Ahmed","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.424_bib16","first-page":"1097","article-title":"Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data","volume":"29","author":"Mrdovic","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib17","first-page":"629","article-title":"Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study","volume":"89","author":"Chandrasekhar","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.01.424_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jcin.2025.01.424_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamacardio.2023.4316","article-title":"Abbreviated or standard dual antiplatelet therapy by sex in patients at high bleeding risk: a prespecified secondary analysis of a randomized clinical trial","volume":"9","author":"Landi","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib20","article-title":"P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials","volume":"373","author":"Valgimigli","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2025.01.424_bib21","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e383","article-title":"Sex-based outcomes of P2Y12 inhibitor monotherapy after three months of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention","volume":"38","author":"Shin","year":"2023","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jcin.2025.01.424_bib22","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1161\/ATVBAHA.122.318725","article-title":"Sex differences in outcomes of ticagrelor therapy with or without aspirin after percutaneous coronary intervention in patients with acute coronary syndrome: a post hoc secondary analysis of the TICO randomized clinical trial","volume":"43","author":"Lee","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2025.01.424_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/ATVBAHA.108.179788","article-title":"Thrombosis and antithrombotic therapy in women","volume":"29","author":"Bailey","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2025.01.424_bib24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14740338.2018.1524869","article-title":"Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease","volume":"17","author":"Romano","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jcin.2025.01.424_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11239-021-02439-x","article-title":"Gender differences with short-term vs 12\u00a0months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial","volume":"52","author":"Verdoia","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jcin.2025.01.424_bib26","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2025.01.424_bib27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Endeavor Zotarolimus-Eluting Stent Implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.01.424_bib28","first-page":"178","article-title":"Short-versus long-term dual antiplatelet therapy after drug-eluting stent implantation in women versus men: a sex-specific patient-level pooled-analysis of six randomized trials","volume":"89","author":"Sawaya","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.01.424_bib29","article-title":"Sex-related differences in patients at high bleeding risk undergoing percutaneous coronary intervention: a patient-level pooled analysis from 4 postapproval studies","volume":"9","author":"Chandiramani","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcin.2025.01.424_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(24)01616-7","article-title":"De-escalation to ticagrelor monotherapy versus 12\u00a0months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials","volume":"404","author":"Valgimigli","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.01.424_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.123.066943","article-title":"Stopping aspirin within 1\u00a0month after stenting for ticagrelor monotherapy in acute coronary syndrome: the T-PASS randomized noninferiority trial","volume":"149","author":"Hong","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.424_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008359","article-title":"Trends in arterial access site selection and bleeding outcomes following coronary procedures, 2011-2018","volume":"15","author":"Doll","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825004959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825004959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:29:26Z","timestamp":1776166166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825004959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1936879825004959"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.01.424","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-Month or 3-Month DAPT in Women and\u00a0Men at High Bleeding Risk Undergoing PCI","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.01.424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}